Additionally, clinical findings support that increased FABP4 serum levels are associated with insulin resistance and secretion in patients with type 2 diabetes mellitus, suggesting that FABP4 plays an important role in peripheral glucose homeostasis (also linked to the onset of AD) [41,42]. Here, FABP4 is linked to type 2 diabetes mellitus.